Viewing Study NCT00892827

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:11 AM
Study NCT ID: NCT00892827
Status: UNKNOWN
Last Update Posted: 2010-09-14
First Post: 2009-05-04
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia
Sponsor: Wolfson Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Refractory Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rituximab View
None Mabthera View
None FFP View
None Fresh Frozen Plasma View
None CLL View
None Complement View
None Response View
None Overall response rate of FFP+Rituximab combined therapy View
None Analysis of complement activation pathways prior to, during and View
None after the study treatment. View
None Time to disease progression View
None Time to re-treatment (See Appendix I). View
None Safety of the combination treatment of FFP and RTX. View